Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
A laboratory test identified by CPT® Code 80360 is specifically designed to measure the levels of methylphenidate and its metabolite, ritalinic acid, in the body. Methylphenidate, commonly known by brand names such as Ritalin, Methylin, and Concerta, is classified as a central nervous system psycho-stimulant. This medication is primarily utilized in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and postural orthostatic tachycardia syndrome. The mechanism of action for methylphenidate involves the enhancement of neurotransmitter levels, particularly dopamine and norepinephrine, within the brain. This increase facilitates improved focus and better control over actions for individuals who may struggle with attention and impulse regulation. The testing process involves obtaining a blood sample through a venipuncture, which is a procedure that can be reported separately, as well as collecting urine either through random voiding or catheterization. The analysis of urine, serum, and plasma samples is conducted using a sophisticated technique known as quantitative liquid chromatography-tandem mass spectrometry, which allows for precise measurement of the substances in question.
© Copyright 2026 Coding Ahead. All rights reserved.
The laboratory test associated with CPT® Code 80360 is indicated for the following conditions:
The procedure for conducting the test under CPT® Code 80360 involves several key steps:
After the procedure, there are no specific post-procedure care requirements mentioned for the test associated with CPT® Code 80360. However, it is important for healthcare providers to monitor the patient’s response to methylphenidate therapy, especially in the context of the conditions being treated. The results of the test can provide valuable information regarding the effectiveness of the medication and help guide further treatment decisions.
| Short Descr | METHYLPHENIDATE | Medium Descr | DRUG SCREENING METHYLPHENIDATE | Long Descr | Methylphenidate | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x) | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T2D - Other tests - other | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Added | Added |
Get instant expert-level medical coding assistance.